Archives

July 12-16, 2026 (London, England) A large group of faculty and staff will represent the MGH FTD Unit in presenting the latest of our exciting research progress at the Alzheimer’s [...]

April 30, 2026 We are pleased to share that Axsome Therapeutics’ Auvelity has been granted FDA approval for the treatment of agitation associated with Alzheimer’s dementia. As the first [...]

June 20, 2026 The fifth episode of the second season of From Care to Cure, a podcast from the Massachusetts General Hospital Frontotemporal Disorders Unit, is available today. In season two, [...]